Search results (154)
« Back to PublicationsMultinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals.
Journal article
Neuen BL. et al, (2026), Nat Med
Hierarchical Composite End Points: The Future of Randomized Trials of Kidney Disease?
Journal article
Staplin N. and Judge PK., (2026), Clin J Am Soc Nephrol
Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy.
Journal article
Zhu D. et al, (2026), Am J Kidney Dis, 87, 564 - 568
Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEY.
Journal article
Malijan GB. et al, (2026), Am J Kidney Dis, 87, 553 - 563.e1
Interplay of Age and Sex With Clinic and Ambulatory Blood Pressure and Mortality.
Journal article
Böhm M. et al, (2026), Hypertension
Association Between 24-Hour Systolic Blood Pressure Time in Target Range and Mortality.
Journal article
Lauder L. et al, (2026), Hypertension
Kidney function and mortality in Mexico: prospective study of 130 000 adults
Journal article
Aguilar Ramirez D. et al, (2026), Kidney Medicine
SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Meta-Analysis.
Journal article
Neuen BL. et al, (2026), JAMA, 335, 233 - 244
Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria: A Meta-Analysis.
Journal article
Staplin N. et al, (2026), JAMA, 335, 220 - 232
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group ., (2026), Lancet Infect Dis, 26, 34 - 45
Effects of empagliflozin on conventional and exploratory acute and chronic kidney outcomes: an individual participant-level meta-analysis.
Journal article
Herrington WG. et al, (2025), Lancet Diabetes Endocrinol, 13, 1003 - 1014
Mortality according to ambulatory blood pressure in hypertensive patients with normal or impaired kidney function.
Journal article
Gorostidi M. et al, (2025), Hypertens Res, 48, 3234 - 3243
An application of the MR-Horse method to reduce selection bias in genome-wide association studies of disease progression.
Journal article
Donovan K. et al, (2025), Eur J Hum Genet, 33, 1677 - 1683
Blood Pressure and Mortality in Mexico City: A Mendelian Randomization Study.
Journal article
Turner M. et al, (2025), Hypertension, 82, 1896 - 1905
Chronic kidney disease and incident cancer risk: an individual participant data meta-analysis.
Journal article
Mok Y. et al, (2025), Br J Cancer, 133, 1535 - 1543